Andrographolide Presents Therapeutic Effect on Ulcerative Colitis Through the Inhibition of IL-23/IL-17 Axis

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2018 Mar 8

PMID 29511440

Citations 20

Authors

Qin Zhu

Peifen Zheng

Xinyu Chen

Feng Zhou

Qiaona He

Yuefeng Yang

Affiliations

Soon will be listed here.

Abstract

Ulcerative colitis (UC) is a chronic and nonspecific intestinal inflammatory disease, which may increase the risk of colon cancer. Andrographolide is a main active component of . The anti-inflammatory ability of andrographolide suggested its potential therapeutic effect against UC. In the present study, elevated serum concentrations of proinflammatory factors, including (TNF)-α, interleukin (IL)-1β, IL-6 and IL-23, as well as increased percentages of Th17 cells (IL-17+CD4+ cells) in CD4+ cells were detected in UC patients compared to that in healthy donors. These data suggested that Th17 immune responses may involve in the pathogenesis of UC. Experimental colitis mouse model was then established. The results of hematoxylin and eosin staining demonstrated the therapeutic effect of andrographolide on colitis. Enzyme-linked immunosorbent assay (ELISA), flow cytometry and western blotting analyses showed that andrographolide could decreased the levels of proinflammatory factors TNF-α, IL-1β, IL-6 and IL-17A in the serum and in the colon tissues, reduced the percentages of Th17 cells in CD4+ cells, and suppressed the levels of IL-23, IL-17A, ROR-γt (key transcription factor of Th17 cells) and p-STAT3 in the colon tissues. Further, peripheral blood mononuclear cells (PBMCs) were isolated from UC patients and treated with various concentrations of andrographolide (0, 10, 20 and 30 μg/ml). Andrographolide also showed inhibitory effects on the levels of proinflammatory factors, the percentages of Th17 cells and the expression of relative proteins. Similar results were obtained in lipopolysaccharide-treated normal PBMCs. These data suggested that andrographolide may inhibit Th17 immune response via STAT3 signaling. In conclusion, we demonstrated that andrographolide inhibited the activity of IL-23/IL-17 axis and down-stream pro-inflammatory factors so as to suppress inflammation response, resulting in the relieving of UC.

Citing Articles

Eudragit S 100 Assisted Molecular Solid Dispersion of Andrographolide Tendered Augmented Drug Delivery and Apoptosis in Human Colon Cancer, HT-29 Cells.

Devangan P, Sharma A, Wadate N, Mourya A, Madan J AAPS PharmSciTech. 2025; 26(3):82.

PMID: 40069524 DOI: 10.1208/s12249-025-03073-z.

Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response.

Shu L, Fu H, Pi A, Feng Y, Dong H, Si C Front Pharmacol. 2024; 15:1424219.

PMID: 39135804 PMC: 11317410. DOI: 10.3389/fphar.2024.1424219.

Knockdown of TOP2A suppresses IL-17 signaling pathway and alleviates the progression of ulcerative colitis.

Li O, Li X, He J Immun Inflamm Dis. 2024; 12(4):e1207.

PMID: 38661103 PMC: 11044219. DOI: 10.1002/iid3.1207.

The progression of inorganic nanoparticles and natural products for inflammatory bowel disease.

Li Q, Lin L, Zhang C, Zhang H, Ma Y, Qian H J Nanobiotechnology. 2024; 22(1):17.

PMID: 38172992 PMC: 10763270. DOI: 10.1186/s12951-023-02246-x.

Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.

Rivera Rodriguez R, Johnson J Pharmacol Ther. 2023; 248:108456.

PMID: 37247693 PMC: 10527092. DOI: 10.1016/j.pharmthera.2023.108456.

References

Liu W, Guo W, Guo L, Gu Y, Cai P, Xie N . Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response. Int Immunopharmacol. 2014; 20(2):337-45. DOI: 10.1016/j.intimp.2014.03.015. View

Yu F, Huang S, Zhang H, Ye H, Chi H, Zou Y . Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients. World J Gastroenterol. 2014; 20(41):15299-309. PMC: 4223263. DOI: 10.3748/wjg.v20.i41.15299. View

Tang T, Targan S, Li Z, Xu C, Byers V, Sandborn W . Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther. 2010; 33(2):194-202. DOI: 10.1111/j.1365-2036.2010.04515.x. View

Sandborn W, Targan S, Byers V, Rutty D, Mu H, Zhang X . Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol. 2012; 108(1):90-8. PMC: 3538174. DOI: 10.1038/ajg.2012.340. View

Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K . A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population. J Am Soc Echocardiogr. 2016; 29(8):794-801.e29. DOI: 10.1016/j.echo.2016.03.017. View

Yu Z, Lu B, Sheng Y, Zhou L, Ji L, Wang Z . Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation. Biochim Biophys Acta. 2015; 1850(4):824-31. DOI: 10.1016/j.bbagen.2015.01.014. View

Park J, Lee J, Lim M, Kim E, Kim S, Ryu J . JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T Cells and Th17 cells. J Immunol. 2014; 192(9):4417-24. DOI: 10.4049/jimmunol.1300514. View

Elson C, Cong Y, Weaver C, Schoeb T, McClanahan T, Fick R . Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology. 2007; 132(7):2359-70. DOI: 10.1053/j.gastro.2007.03.104. View

Hartmann F, Stein J . Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis. Aliment Pharmacol Ther. 2010; 32(3):368-76. DOI: 10.1111/j.1365-2036.2010.04354.x. View

10.

Fragoulis G, Siebert S, McInnes I . Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases. Annu Rev Med. 2015; 67:337-53. DOI: 10.1146/annurev-med-051914-021944. View

11.

Hindryckx P, Baert F, Hart A, Magro F, Armuzzi A, Peyrin-Biroulet L . Clinical trials in ulcerative colitis: a historical perspective. J Crohns Colitis. 2015; 9(7):580-8. DOI: 10.1093/ecco-jcc/jjv074. View

12.

Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls J . Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis. 2006; 12(5):382-8. DOI: 10.1097/01.MIB.0000218764.06959.91. View

13.

Scheiffele F, Fuss I . Induction of TNBS colitis in mice. Curr Protoc Immunol. 2008; Chapter 15:Unit 15.19. DOI: 10.1002/0471142735.im1519s49. View

14.

Iskandar H, Dhere T, Farraye F . Ulcerative Colitis: Update on Medical Management. Curr Gastroenterol Rep. 2015; 17(11):44. DOI: 10.1007/s11894-015-0466-9. View

15.

Ayyoub M, Deknuydt F, Raimbaud I, Dousset C, Leveque L, Bioley G . Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A. 2009; 106(21):8635-40. PMC: 2688993. DOI: 10.1073/pnas.0900621106. View

16.

Mohammadi M, Hayatbakhsh M, Zahedi M, Jalalpour M, Pakgohar A . Serum interleukin-23 levels in patients with ulcerative colitis. Iran J Immunol. 2011; 8(3):183-8. DOI: IJIv8i3A6. View

17.

Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S . Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2009; 30(1):80-9. DOI: 10.1007/s10875-009-9345-1. View

18.

Parichatikanond W, Suthisisang C, Dhepakson P, Herunsalee A . Study of anti-inflammatory activities of the pure compounds from Andrographis paniculata (burm.f.) Nees and their effects on gene expression. Int Immunopharmacol. 2010; 10(11):1361-73. DOI: 10.1016/j.intimp.2010.08.002. View

19.

Scarpa M, Castagliuolo I, Castoro C, Pozza A, Scarpa M, Kotsafti A . Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World J Gastroenterol. 2014; 20(22):6774-85. PMC: 4051917. DOI: 10.3748/wjg.v20.i22.6774. View

20.

Xiong H, Zhang Z, Tian X, Sun D, Liang Q, Zhang Y . Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia. 2008; 10(3):287-97. PMC: 2259457. DOI: 10.1593/neo.07971. View